A clinical trial published in the New England Journal of Medicine has shown that bionic pancreas which can automatically deliver insulin is more beneficial to people with Type 1 Diabetes for blood glucose management than using insulin syringes or pens..The 13-week trial had 326 participants with Type 1 Diabetes who were aged 6 to 79 years and had been taking insulin for at least one year. The participants were divided randomly in one of two groups one who were using bionic pancreas and the other using their personal insulin delivery method. Those participants who were using bionic pancreas were provided with a continuous glucose meter to monitor their blood glucose levels.The study showed that use of bionic pancreas improved HbA1c from 7.9 percent to 7.3 percent, yet HbA1c remained unchanged among the other group. The group using bionic pancreas spent 11 per cent more time (approximately 2.5 hours per day) within the targeted blood glucose range compared to the other group. The drop in HbA1c levels was seen in youth and adult participants. The study also showed that better blood glucose control was achieved by those participants who had higher blood glucose levels at the beginning of the study.